Yangyang, Charishtemy W.

HRN: 15-37-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2026
CEFUROXIME 500MG (TAB)
07/31/2026
08/06/2026
PO
500mg
Q12h
Thinly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines